Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study
AbstractBackground Iguratimod has been shown to promote bone formation and inhibit bone resorption in rheumatoid arthritis patients. We aimed to explore its effect on bone metabolism and vascular calcification (VC) in kidney transplant recipients (KTRs).Methods A post hoc analysis was conducted amon...
Main Authors: | Li Sun, Jun Tao, Zhijian Han, Hao Chen, Zhengkai Huang, Zijie Wang, Shuang Fei, Chuanjian Suo, Xiaobing Ju, Ruoyun Tan, Min Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2023.2256418 |
Similar Items
-
Vascular calcification progression and its association with mineral and bone disorder in kidney transplant recipients
by: Li Sun, et al.
Published: (2023-12-01) -
Left ventricular remodeling and its association with mineral and bone disorder in kidney transplant recipients
by: Li Sun, et al.
Published: (2024-12-01) -
Mineral and bone disorder after kidney transplantation: a single-center cohort study
by: Li Sun, et al.
Published: (2023-12-01) -
Aortobifemoral Bypass in Kidney Transplant Candidates: A Ten-Year Experience
by: Pascaline Bonnin, et al.
Published: (2024-02-01) -
Aorto-Iliac Artery Calcification Prior to Kidney Transplantation
by: Stan Benjamens, et al.
Published: (2020-09-01)